Kilpatrick, Deborah, PhD

VP of Commercial, CardioDx


Deborah Kilpatrick, Ph.D., is currently Senior Vice President of Commercial at CardioDx in Palo Alto, CA. She joined CardioDx in 2006 as Vice President, Market Development, with responsibility for building the product marketing and reimbursement capabilities of the company. Dr. Kilpatrick oversees commercial functions that include product marketing, managed care marketing, managed care sales, and customer service. In 2010, the company was recognized in the Wall Street Journal Technology Innovation Awards and in TIME Magazine's Top 10 Medical Breakthroughs of the year for its Corus CAD product, the first-ever genomic diagnostic for obstructive coronary artery disease. Prior to joining CardioDx she spent nine years at Guidant Corporation where her roles included Research Fellow, Director of Research and Technology Development, and Director of New Ventures, with focus on incubating new therapy programs in coronary and structural heart disease. Early in her career, Dr. Kilpatrick was a structural engineer at Pratt and Whitney for U.S. military aircraft engine programs, including the F22 Raptor. She now serves on the Advisory Boards for the Georgia Institute of Technology and for its College of Engineering. She is on the Board of Directors for the Dystonia Medical Research Foundation and on the Community Advisory Council for El Camino Hospital of Silicon Valley. Deborah is a Fellow of the American Institute of Medical and Biological Engineering and has received a Rising Star award from the Healthcare Businesswoman's Association. Dr. Kilpatrick holds multiple U.S. patents and a Ph.D. in mechanical engineering with a focus in cardiovascular bioengineering from the Georgia Institute of Technology. She also holds a B.S. degree in Engineering Science & Mechanics and an M.S. degree in Mechanical Engineering from the Georgia Institute of Technology.

Listen to an interview with Deborah